Regional distribution of specific high affinity binding sites for 3H-imipramine and 3H-paroxetine in human brain

Journal of Neural Transmission

Volumn 104, Issue 1, 1997, Pages 89-96

  Rosel, P ^a   Menchon, J M ^a   Oros, M ^a   Vallejo, J ^a   Cortadellas, T ^a   Arranz, B ^a,b   Alvarez, P ^a   Navarro, M A ^a  

^a HOSPITAL UNIVERSITARI DE BELLVITGE   (Spain)

^b INST MUNIC D INVESTIGACIO MEDICA   (Spain)

Author keywords

3H imipramine; 3H paroxetine; Human brain; Suicide victims

Indexed keywords

IMIPRAMINE; PAROXETINE; RADIOLIGAND; SEROTONIN;

ADULT; AGED; ARTICLE; BASAL GANGLION; BINDING AFFINITY; BINDING SITE; BRAIN REGION; CINGULATE GYRUS; CONTROLLED STUDY; DRUG DISTRIBUTION; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPOTHALAMUS; MALE; MEMBRANE BINDING; NERVE CELL MEMBRANE; PRIORITY JOURNAL; SEROTONIN UPTAKE; THROMBOCYTE MEMBRANE;

ADULT; AGED; BRAIN; HUMANS; IMIPRAMINE; MALE; MEMBRANE PROTEINS; MIDDLE AGED; PAROXETINE; PROTEIN BINDING; RADIOLIGAND ASSAY; TISSUE DISTRIBUTION;

EID: 0031026376     PISSN: 03009564     EISSN: None     Source Type: Journal    
DOI: 10.1007/BF01271297     Document Type: Article

References (36)

1. Arranz B, Marcusson J (1994) 3H-Paroxetine and 3H-citalopram as markers of the human brain 5-HT uptake site: a comparison study. J Neural Transm 97: 27-40
2. Asarch KB, Shin JC, Kuleasar A (1988) Decreased 3H-imipramine binding in depressed males and females. Commun Psychopharmacol 4: 425-432
3. Backstrom IT, Marcusson JO (1987) 5 Hydroxytryptamine-sensitive 3H imipramine binding of protein nature in the human brain. I. Characteristics. Brain Res 425: 128-136
4. Backstrom IT, Bergstrom M, Marcusson J (1989) High affinity 3H paroxetine binding to serotonine uptake sites in human brain tissue. Brain Res 486: 261-268
5. Briley MS, Langer SZ, Raisman R, Sechter D, Zarifian E (1980) Tritiated 3H-imipramine binding sites are decreased in platelet of untreated depressed patients. Science 209: 303-305
6. Bucht G. Adolfsson R, Gottfries CG, Ross BE, Winblad B (1981) Distribution of 5-hydroxytryptamine and 5- hydroxyindolic acid in human brain in relation to age, drug influence, agonal status and circadian variation. J Neural Transm 51: 185-203
7. Dewar KM, Reader TA, Grondin L, Descarries L (1991) 3H-paroxetine binding and serotonin content of rat and rabbit cortical areas, hyppocampus, neostriatum, ventral mesencephalic tegmentum and midbrain raphe nuclei region. Synapse 9: 14-18
8. Gobbi M, Taddei C, Mennini T (1997) Different components of 3H-imipramine binding in rat brain membranes: relation to serotonin uptake sites. Life Sci 42: 575-583
9. Habert E, Graham D, Tahraoui L, Claustre Y, Langer SZ (1985) Characterization of 3H-paroxetine binding to rat cortical membranes. Eur J Pharmacol 118: 107-114
10. Hrdina PD (1984) Differentiation of two components of specific 3H imipramine binding in rat brain. Eur J Pharmacol 102: 481-488
11. Hrdina PD (1987) Sodium dependent 3H-imipramine binding in rat hippocampus and its relationship to serotonin uptake. Can J Physiol Pharmacol 65: 2422-2427
12. Hrdina PD (1988) Inhibition of sodium dependent 3H-imipramine binding in rat brain by serotonin and serotonin uptake inhibitors. Eur J Pharmacol 147: 279-282
13. Hrdina PD (1989) Differences between sodium dependent and desipramine defined 3H-imipramine binding in intact human platelets. Biol Psychiatry 576-584
14. Hrdina PD, Foy B, Hepher A, Summer RJ (1990a) Antidepressant binding sites in brain: autoradiographic comparison of 3H-paroxeline and 3H-imipramine localization and relation to serotonine transporter. J Pharmacol Exp Ther 252: 410-418
15. Hrdina PD, Foy B, Summer RJ (1990b) 2D Imaging of serotonin uptake sites in brain with 3H-paroxetine: comparisom with 3H-imipramine. In: Leonard B, Spenser P (eds) Antidepressant: thirty years on. Portland Press LTD, pp 54-59
16. Langer SZ, Moret C, Raisman R, Dubocovich ML, Briley MS (1980) High-affinity 3H-imipramine binding in rat hippothalamus: association with uptake of serotonin but not of norepinephrine. Science 210: 1133-1135
17. Langer SZ, Javoy-Agid F, Raisman R, Briley M, Agid J (1981) Distribution of specific high affinity binding sites for 3H-imipramine in human brain. J Neurochem 37: 267-271
18. Langer SZ, Galzin AM, Poirier MF, Loo H, Sechter D, Zarifian E (1987) Association of 3H-imipramine and 3H-paroxetine binding with the 5HT transporter in brain and platelets: relevance to studies in depression. J Recept Res 7: 499-521
19. Marcusson J, Fowler CJ, Hall H, Ross SB, Winblad B (1985) "Specific" binding of 3H-imipramine to protease-sensitive and protease-resistent sites. J Neurochem 44: 705-711
20. Marcusson JO, Backstrom IT, Ross SB (1986) Single-site model of the neural 5 hydroxytryptamine uptake and imipramine binding site. Mol Pharmacol 30: 121-154
21. Marcusson J, Alafuzoff I, Backstrom IT, Ericson E, Gotffries CG, Winblad B (1987) 5 hydroxytryptamine-sensitivc 3H-imipramine binding of protein nature in the human brain. II. Effect of normal aging and dementia disorders. Brain Res 425: 137-145
22. Marcusson JO, Bergstrom M, Eriksson K, Ross SB (1988) Characterization of 3H-paroxetine binding in rat brain. J Neurochem 50: 1783-1790
23. Markwell MA, Haas SM, Bieber LL, Tolbert NE (1987) A modification of the Lowry procedure to simplify protein determination in membrane and lipoprotein samples. Anal Biochem 87: 203-225
24. Mellerup ET, Plenge P (1986) High affinity binding of 3H-paroxetine and 3H-imipramine to rat neural membranes. Psychopharmacology 89: 436-439
25. Moret C, Briley M (1991) Platelet 3H-paroxetine binding to the serotonin transporter is insensitive to changes in central serotoninergic innervation in the rat. Psychiatry Res 38: 97-104
26. Palkovits M, Raisman R, Briley M, Langer SZ (1981) Regional distribution of 3H-imipramine binding in rat brain. Brain Res 210: 493-498
27. Paul SM, Rehavi M, Rice KC, Utah Y, Skolnick P (1981) Does high affinity 3H-imipramine binding label serotonin reuptake sites in brain and platelets? Life Sci 28: 2753-2760
28. Plenge P, Mellerup ET, Laursen H (1990) Regional distribution of the serotonin transport complex in human brain, identified with 3H-paroxetine 3H citalopram and 3H-imipramine. Prog Neuropsychopharmacol 14: 61-72
29. Plenge P, Mellerup ET, Laursen H (1991) Affinity modulation of 3H-imipramine, 3H-paroxetine and 3H-citalopram binding to the 5HT transporter from brain and platelets. Eur J Pharmacol 206: 243-250
30. Raisman R, Briley MS, Langer SZ (1979) High affinity 3H-imipramine binding in rat cerebral cortex. Eur J Pharmacol 58: 347-348
31. Raisman R, Sechter D, Briley MS, Zarilian E, Langer SZ (1981) High affinity 3H-imipramine binding in platelets from untreated and treated depressed patients compared to healthy volunteers. Psychopharmacology 77: 332-335
32. Rosel P, Vallejo J, Oros M, et al (1995) Changes in platelet 3H-imipramine binding: influences of protein concentration of varying proportions of cytosol or intact platelets and displacing agents used. Biol Psychiatry 38/7: 464-470
33. Rosel P, Vallejo J, Oros M, et al (1996) Seasonal variability in blood platelet 3H-imipramine binding in healthy controls: age and gender effects. Biol Psichiatry in press
34. Severson JA, Marcusson JO, Osterburg HH, Finch CE, Winblad B (1985) Elevated density of 3H-imipramine binding in aged human brain. J Neurochem 45: 1382-1389
35. Sette M, Ruberg M, Raisman R, Scattom B, Zivkovic B, Agid Y, Langer SZ (1983) 3H-imipramine binding in subcellular fractions of rat cerebral cortex after chemical lesion of serotoninergic neurons. Eur J Pharmacol 95: 41-51
36. Suranyi-Cadotte B, Quirion R, Mc Quade P, et al (1984) Platelet 3H-imipramine binding: a state-dependent marker in depression. Neurosychopharmacol 8: 737-741